Delivery Order SPE2DE21D7020-SPE2D625F3PPM
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $22,089.58 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of June 9, 2025. This fixed-price contract with economic price adjustment represents a non-competitive award with no set-aside designation. The contract will be performed at Boston Scientific's headquarters facility in Marlborough, Massachusetts, where the company manufactures and distributes advanced medical devices and...
- Boston Scientific Corp has been awarded a delivery order valued at $12,695.76 by the Defense Health Agency's Medical Supply Chain, an organization within the Department of Defense responsible for procuring medical devices and supplies for military healthcare systems. The contract, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, represents a fixed-price agreement with economic price adjustment provisions. The work will be performed at Boston Scientific's headquarters...
- Boston Scientific Corp has been awarded a delivery order valued at $15,928.65 by the Defense Health Agency's Medical Supply Chain for the supply of medical devices and equipment. The contract, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a...
- Boston Scientific Corp has been awarded a delivery order valued at $41,218.20 by the Defense Health Agency's Medical Supply Chain for the provision of medical devices and supplies. The contract, awarded on July 28, 2025, utilizes a fixed-price structure with economic price adjustment provisions and is set to reach completion by July 31, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a non-set-aside competitive procurement,...
- Boston Scientific Corp has been awarded a delivery order valued at $2,762.81 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award to the prime contractor, with performance taking place at Boston Scientific's headquarters in Marlborough, Massachusetts. As a global medical technology company, Boston Scientific provides critical medical devices and...
- Boston Scientific Corp has been awarded a delivery order valued at $1,616.07 by the Defense Health Agency's Medical Supply Chain, a defense-focused federal healthcare procurement entity. The contract, issued on September 8, 2025, with an ultimate completion date of September 15, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $1,103.52 to Boston Scientific Corp on August 28, 2025, with an ultimate completion date of September 5, 2025. This fixed-price contract with economic price adjustment utilizes no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp, a leading medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $19,908 under the Defense Health Agency's Medical Supply Chain program. The contract, issued on September 10, 2025, with an ultimate completion date of September 17, 2025, utilizes a fixed-price pricing structure with economic price adjustment provisions. This delivery order is not associated with a set-aside designation, indicating Boston...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3PPMDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $22,264.80 by the Defense Health Agency's Medical Supply Chain for the supply of medical devices and equipment. The contract, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. Performance will take place at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures and distributes its portfolio of advanced medical technologies. This delivery order falls under the Defense Health Agency's broader Medical Supply Chain procurement vehicle, through which Boston Scientific serves as a prime contractor providing specialized medical devices to federal healthcare agencies. As a leading medical technology company, Boston Scientific supplies critical equipment including cardiovascular intervention tools, implantable devices, diagnostic systems, and other advanced medical technologies to support the Department of Defense's healthcare operations. The modest contract value reflects a specific delivery order within the company's larger relationship with the Defense Health Agency for medical device supply and support services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 9/16/25 |